Company’s human nutrition and health business unit showcases science-backed ingredients that help maintain a positive health ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most ...

This infographic highlights the key advantages of CHO cells and the technologies that are pushing the boundaries of cell ...

Wojciech Jurczak, MD, PhD, ​​discusses the future of B-cell lymphoma therapy, with a focus on Bruton's tyrosine kinase ...

B-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it ...

Study reveals B cells suppress mutations during rapid division, enhancing immune response and offering critical insights for ...

A study focusing on analyzing cell models found universality in their movement—an important discovery that could impact both ...

The first webinar focuses on diseases originating from the B-cell lineage. Join Jennifer McCallister, an esteemed expert in the field, as she provides insights into the diagnosis of B-cell neoplasms.

Glioblastoma, one of the most aggressive and lethal brain cancers, has a five-year survival rate of only 6.9%, according to the National Brain Tumor Society. While the relationship between ...

Advancing science and technology to build a healthier, cleaner and safer world. Thermo Fisher Scientific is a global leader in protein and cell analysis, offering advanced tools and solutions to ...

Stocks like Maruti Suzuki India, Minda Corporation, Oil and Natural Gas Corporation, Siemens India, Brainbees Solutions, TVS ...

Mar. 11, 2025 — Researchers have identified genetic changes in blood stem cells from frequent blood donors that support the production of new, non-cancerous cells. Understanding the differences ...